Antigen receptor inputs: linking structural, molecular, and cellular responses
Antigen receptor inputs: linking structural, molecular, and cellular responses
批准号:
7868850
负责人:
JONATHAN P SCHNECK
金额:
$35.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2011-08-31
中文摘要
该计划的首要目标是了解调节细胞的分子机制,
activation.通过特异性识别抗原的淋巴细胞的激活,
利益和风险,因此受到严格的监管。我们知道,有些信号是用来调节或
终止激活,而其他信号诱导细胞无反应或死亡。的分子机制
具有不同结果的监管过程的基础是未知的,而且在很大程度上是不确定的。
该计划包括五个高度互动的项目,涉及六名调查人员,来自五个不同的
大学的部门。这些研究人员带来了创新的技术和精辟的想法,
淋巴细胞活化及其调节的问题。这五个项目涵盖了一系列的刺激,线索和
结果导致T细胞活化或无反应的各种状态,从最初的事件,
抗原识别对转录的调节。这些项目涵盖了从纳米级到生物级的
分子间相互作用与全细胞和动物模型。该方案涉及以下领域:1)
TCR空间组织对T细胞应答的影响,2)TCR空间组织的分子结构改变,
免疫突触和T细胞无反应性,3)Sprouty 1作为T细胞活化的新型抑制剂,4)调节
5)TCR和共刺激信号对NF-κ B的调节。这些
五个项目支持了解调节细胞活化的分子机制的总体目标。
该计划是在一个核心调查小组多年互动的基础上发展起来的,
两年来,有新同事加入。调查人员之间的互动正在蓬勃发展。的
从详细的项目说明中可以明显看出小组成员之间协同作用的程度。
我们希望了解T细胞对抗原反应的机制。了解这些机制
会导致产生或关闭有益或有害的免疫反应。
英文摘要
The overarching goal of this Program is to understand the molecular mechanisms that regulate cell
activation. Activation of lymphocytes through specific recognition of antigen poses narrowly balanced
benefits and risks, and hence is subject to tight regulation. We know that some signals serve to modulate or
terminate activation, while other signals induce cell unresponsiveness or death. The molecular mechanisms
underlying the regulatory processes with different outcomes are unknown and largely undefined.
The Program consists of five highly interactive projects involving six investigators, from five different
departments of the University. These investigators bring innovative technology and incisive ideas to bear on
the problem of lymphocyte activation and its regulation. The five projects cover a range of stimuli, cues and
outcomes that result in various states of T cell activation or unresponsiveness, from the initial events of
antigen recognition to the regulation of transcription. The projects cover a biological scale from nano-scale
molecular interactions to whole cell and animal models. The program addresses the following areas: 1)
Influence of TCR spatial organization on T cell responses, 2) Altered molecular architecture at the
Immunological Synapse and T cell anergy, 3) Sprouty 1 as a novel inhibitor of T cell activation, 4) Regulation
of calcium signaling in T cells by TFII-I, 5) Regulation of NF-kB by TCR and costimulatory signaling. These
five projects support the overall goal of understanding the molecular mechanisms regulating cell activation.
The program has developed out of years of interaction among a core group of investigators who in the last
two years have been joined by new colleagues. Interactions between investigators are flourishing. The
extent of synergy between group members is apparent from the detailed project descriptions.
We want to understand the mechanisms of T cell responses to antigen. Understanding these mechanisms
will lead to ways of turning up, or turning off immune responses that are helpful or harmful.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
-
批准号:10167008
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2020
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10436868
-
项目类别:
-
资助金额:$116.72万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:10645127
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:10436869
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10017988
-
项目类别:
-
资助金额:$117.37万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:10223292
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10645124
-
项目类别:
-
资助金额:$115.98万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:9790436
-
项目类别:
-
资助金额:$61.37万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:10223293
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
-
批准号:9916739
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:9790435
-
项目类别:
-
资助金额:$170.74万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10223291
-
项目类别:
-
资助金额:$115.03万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:10436870
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:10645125
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:9790437
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:8318879
-
项目类别:
-
资助金额:$200.98万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:7914320
-
项目类别:
-
资助金额:$201.98万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:7687424
-
项目类别:
-
资助金额:$198.21万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:8137710
-
项目类别:
-
资助金额:$200.75万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Profiling of influenza-specific immune responses in the elderly
-
批准号:7393029
-
项目类别:
-
资助金额:$24.58万
-
财政年份:2007
-
负责人:JONATHAN P SCHNECK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
-
批准号:82370797
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陶弢
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
拟南芥中水杨酸介导花粉管生长的受体筛选及其分子机理研究
-
批准号:32100576
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:荣朵艳
-
依托单位:
Nek9磷酸化MCL-1调控线粒体自噬和分裂的机制与功能研究
-
批准号:32100598
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:岑旭峰
-
依托单位:
褪黑素促进MCL-1抑制剂诱导白血病细胞凋亡的分子机制研究
-
批准号:32100607
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:叶开琴
-
依托单位: